Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 11.36% | -1.28pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 12.64% | -1.09pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 13.73% | -0.89pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 14.62% | -1.00pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 15.62% | -1.13pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 16.75% | -0.57pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 17.32% | -1.08pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 18.40% | -1.08pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 19.48% | -1.42pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 20.90% | +16.48pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.